% latex table generated in R 4.0.1 by xtable 1.8-4 package
% Mon Apr 11 16:14:35 2022
\begin{table}[ht]
\centering
\begingroup\tiny
\begin{tabular}{rlllrlllllrrrr}
  \hline
 & Study ID & Number of patients included & modality\_group & Number of margins included & Study design & HNSCC sub-sites included in study & Mean age & Population description & Modality Diagnostic tool 1 & TN & TP & FN & FP \\ 
  \hline
1 & Leunig 2001 & 24 & Topical Staining & 49.00 & Prospective cohort study & Oral Cancer &  &  & 5-ALA fluorescence staining & 50.00 & 18.00 & 5.00 & 25.00 \\ 
  2 & Pandey 2019 & 104 & Frozen Section & 470.00 & Retrospective cohort study & Oral Cancer & not reported & 59M:45F & Frozen section: specimen-driven & 440.00 & 22.00 & 6.00 & 2.00 \\ 
  3 & Tirelli 2019 & 182 & Frozen Section & 785.00 & Retrospective cohort study & Oral Cancer & 68 & 103M:79F & Patient driven frozen section & 726.00 & 31.00 & 14.00 & 14.00 \\ 
  4 & Tirelli 2019 & 42 & Frozen Section & 283.00 & Prospective cohort study & Multiple sub-sites & 70 (median) & 26M:16F & Defect-driven frozen section & 180.00 & 88.00 & 6.00 & 9.00 \\ 
  5 & Putri 2021 & 26 & Topical Staining & 40.00 & Prospective cohort study &  & 45 (all tumour types, not just HNSCC) & 50M:100F (all tumour types, not just HNSCC) & Multistaining (acetic acid \& iodine) & 3.00 & 43.00 & 3.00 & 5.00 \\ 
  6 & Aisner 1997 & 49 & Frozen Section & 307.00 & Retrospective cohort study & Oral Cancer & Not reported & 32M:17F & Frozen section & 291.00 & 13.00 & 2.00 & 1.00 \\ 
  7 & Tirelli 2015 & 16 & Optical Techniques & 32.00 & Prospective cohort study & Multiple sub-sites & 64 & 11M:5F & Narrow band imaging & 14.00 & 16.00 & 2.00 & 0.00 \\ 
  8 & Layfield 2018 & 288 & Frozen Section &  & Retrospective cohort study & Multiple sub-sites & Not stated & Not stated. & Frozen section -specimen driven. & 1452.00 & 289.00 & 35.00 & 20.00 \\ 
  9 & Abbas 2017 & 77 & Frozen Section &  & Retrospective cohort study & Oral Cancer & 49 & Study from Pakistan - M45:32F - high levels of buccal cancer (38\%) & Frozen section & 62.00 & 8.00 & 3.00 & 4.00 \\ 
  10 & Amit 2016 & 71 & Frozen Section & 161.00 & Randomised controlled trial & Oral Cancer & 61 & 44M:27F & Specimen-driven frozen section & 164.00 & 21.00 & 2.00 & 12.00 \\ 
  11 & Amit 2016 & 71 & Frozen Section & 161.00 & Randomised controlled trial & Oral Cancer & 61 & 44M:27F & Patient-drive frozen section & 30.00 & 7.00 & 25.00 & 0.00 \\ 
  12 & vanKeulen 2019 & 6 & Chemiluminescence & 39.00 & Prospective cohort study &  &  &  & Chemiluminescence & 108.00 & 37.00 & 2.00 & 13.00 \\ 
  13 & Voskuil 2020 & 13 & Chemiluminescence & 13.00 & Prospective cohort study & Multiple sub-sites &  &  & Chemoluminescence & 4.00 & 6.00 & 0.00 & 3.00 \\ 
  14 & Voskuil 2020 & 15 & Chemiluminescence & 15.00 & Non-randomised experimental study & Multiple sub-sites & 62 & M8:F7 & Chemiluminescence Cetuximab-800CW & 10.00 & 4.00 & 0.00 & 1.00 \\ 
  15 & Herruer 2020 & 61 & Frozen Section & 50.00 & Prospective cohort study & Multiple sub-sites & 60 & M51:F11 & Frozen section - specimen driven & 45.00 & 1.00 & 4.00 & 0.00 \\ 
  16 & Tirelli 2018 & 61 & Optical Techniques & 61.00 & Prospective cohort study & Multiple sub-sites & 67 & oscc and opscc & Narrow band imaging & 16.00 & 34.00 & 2.00 & 9.00 \\ 
  17 & Zafar 2020 & 32 & Touch Imprint Cytology & 130.00 & Prospective cohort study & Oral Cancer & Only range reported. & 24M:8F & Touch Imprint Cytology (H\&E) & 75.00 & 24.00 & 31.00 & 0.00 \\ 
  18 & Datta 2019 & 1311 & Frozen Section & 1237.00 & Retrospective cohort study & Oral Cancer &  &  & specimen driven frozen section & 971.00 & 196.00 & 70.00 & 0.00 \\ 
  19 & Lisul 2019 & 21 & Optical Techniques & 46.00 & Prospective cohort study & Oral Cancer & 63 & 11M:10F & Optomagnetic Imaging Spectroscopy & 20.00 & 18.00 & 5.00 & 3.00 \\ 
  20 & Warram 2016 & 3 & Chemiluminescence & 90.00 & Prospective cohort study & Multiple sub-sites &  &  & Chemiluminescence & 178.00 & 137.00 & 14.00 & 31.00 \\ 
  21 & Heuke 2016 &  & Optical Techniques & 30.00 & Prospective cohort study & Multiple sub-sites &  & 9M:1F & Nonlinear microscopy & 11.00 & 16.00 & 1.00 & 2.00 \\ 
  22 & Hamdoon 2016 & 28 & Optical Techniques & 112.00 & Prospective cohort study & Oral Cancer & 61 & 19M:9F & Optical Coherence Tomography & 80.00 & 18.00 & 4.00 & 10.00 \\ 
  23 & Ohnishi 2016 & 20 & Autofluorescence & 60.00 & Prospective cohort study & Oral Cancer &  &  & Tissue autofluorescence (VELScope) & 7.00 & 48.00 & 5.00 & 0.00 \\ 
  24 & Ohnishi 2016 & 20 & Autofluorescence & 60.00 & Prospective cohort study & Oral Cancer &  &  & Tissue autofluorescence (VELScope) & 11.00 & 13.00 & 1.00 & 35.00 \\ 
  25 & Du 2016 & 253 & Frozen Section &  & Retrospective cohort study & Multiple sub-sites & 63 & M171:82F, 26/253 prior RT & Frozen section & 930.00 & 113.00 & 42.00 & 16.00 \\ 
  26 & Junaid 2012 & 56 & Topical Staining & 280.00 & Prospective cohort study & Oral Cancer & 50 & M42:14F & Toluidine blue & 269.00 & 3.00 & 0.00 & 8.00 \\ 
  27 & Vila 2012 & 38 & Optical Techniques & 252.00 & Prospective cohort study & Multiple sub-sites &  &  & HRME & 60.00 & 183.00 & 3.00 & 6.00 \\ 
  28 & Gao 2018 & 6 & Chemiluminescence & 186.00 & Non-randomised experimental study & Multiple sub-sites & 65 & M2:F4, 1 previous radiotherapy & Fluorescence imaging & 107.00 & 41.00 & 0.00 & 38.00 \\ 
  29 & Slooter 2018 & 7 & Topical Staining & 32.00 & Prospective cohort study & Oral Cancer &  &  & Topical chemoluminescence & 12.00 & 13.00 & 0.00 & 7.00 \\ 
  30 & Naveed 2017 & 52 & Touch Imprint Cytology &  & Prospective cohort study & Multiple sub-sites & 53 & 47M:23F & Touch Imprint Cytology & 2.00 & 50.00 & 0.00 & 0.00 \\ 
  31 & Hoesli 2017 & 50 & Optical Techniques & 84.00 & Prospective cohort study & Multiple sub-sites &  &  & Coherent Raman Scattering Microscopy & 40.00 & 37.00 & 5.00 & 2.00 \\ 
  32 & Chaturvedi 2014 & 141 & Frozen Section & 565.00 & Prospective cohort study & Oral Cancer &  &  & Frozen section: specimen driven & 529.00 & 27.00 & 9.00 & 0.00 \\ 
  33 & Yadav 2013 & 30 & Touch Imprint Cytology & 348.00 & Prospective cohort study & Oral Cancer & 60 (median) & 15M:15F - high levels of Areca nut use & Touch Imprint Cytology & 125.00 & 164.00 & 16.00 & 43.00 \\ 
  34 & Grillone 2017 & 34 & Optical Techniques & 174.00 & Prospective cohort study & Oral Cancer & 59 & 15M:19F & Elastic Scattering Spectroscopy & 70.00 & 64.00 & 12.00 & 28.00 \\ 
  35 & Miles 2015 & 33 & Optical Techniques & 98.00 & Non-randomised experimental study & Multiple sub-sites & Not reported & Not reported & HRME & 60.00 & 32.00 & 1.00 & 3.00 \\ 
  36 & DiNardo 2000 & 80 & Frozen Section &  & Retrospective cohort study & Multiple sub-sites & 58.5 & 56M:24F & Frozen section: patient-driven & 389.00 & 24.00 & 3.00 & 4.00 \\ 
  37 & Saltzstein 1973 & not reported & Frozen Section & 96.00 & Retrospective cohort study & Multiple sub-sites & not recorded & not recorded & Frozen section & 73.00 & 22.00 & 0.00 & 1.00 \\ 
   \hline
\end{tabular}
\endgroup
\caption[full caption]{short caption} 
\label{tab:study_details}
\end{table}
